September 19, 2014
2:00 PM – 3:00 PM EDT
Over the past 3 decades, the NIH has been a global leader in HIV/AIDS research investment, but much work is needed before we see an end to this pandemic. Research on HIV prevention, care, treatment, and cure, like the rest of the HIV/AIDS response is challenged by an increasingly constrained budget. Success requires a reassessment and focus of the scarce resources available on the highest science priorities in the field—those that are most likely to have the greatest population-level impact in the near- and long-term.
Recommendations from a panel of experts in science and community advocacy about what these priorities should be will be presented.